A Double-Blind, Randomized, Parallel Design Study of Aliskiren Versus Hydrochlorothiazide in Mild-to Moderate Hypertensive Type II Diabetes Mellitus Patients on Remodeling of Resistance Arteries

Trial Profile

A Double-Blind, Randomized, Parallel Design Study of Aliskiren Versus Hydrochlorothiazide in Mild-to Moderate Hypertensive Type II Diabetes Mellitus Patients on Remodeling of Resistance Arteries

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 20 May 2015

At a glance

  • Drugs Aliskiren (Primary) ; Hydrochlorothiazide
  • Indications Secondary hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 May 2015 Status changed from suspended to withdrawn prior to enrolment as reported by ClinicalTrials.gov.
    • 05 Jan 2012 Status changed from not yet recruiting to suspended as reported by ClinicalTrials.gov.
    • 01 Dec 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top